Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated to Speak at JMP Securities Healthcare Conference
SUNNYVALE, Calif., Sept 20, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the JMP Securities Healthcare Conference in New York City on Tuesday, September 28, 2010 at
Toggle Summary Benefits of CyberKnife(R) Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology
Conference Presentations Highlight CyberKnife Motion Management Capabilities in Treatment of Lung Cancer SUNNYVALE, Calif., Sept 17, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that for the first time in Europe
Toggle Summary Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference
SUNNYVALE, Calif., Sept 16, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the UBS Global Life Sciences Conference
Toggle Summary Cancer Center to be the First in Europe to Install a CyberKnife VSI System, the Latest Generation of the CyberKnife System
The Léon-Bérard Center of Lyon, France, is now offering its cancer patients the benefits of Full Body Radiosurgery   SUNNYVALE , Calif. , September 1, 2010  – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the first CyberKnife VSI
Toggle Summary Accuray Announces Results for Fourth Quarter and Fiscal Year 2010
Strong CyberKnife(R) Orders Highlight Quarter and Fiscal Year SUNNYVALE, Calif., Aug 31, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year 2010, ended June 30,
Toggle Summary Accuray's CyberKnife(R) G4 System Receives Shonin Approval
Latest Advances in CyberKnife Radiosurgery Now Available in Japan SUNNYVALE, Calif., Aug 03, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and
Toggle Summary Accuray Incorporated's CEO to Speak at BMO Capital Markets' Tenth Annual Focus on Healthcare Conference
SUNNYVALE, Calif., Aug 02, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the BMO Capital Markets' Tenth Annual
Toggle Summary Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2010
SUNNYVALE, Calif., July 28, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its fourth quarter and fiscal year 2010, ended June 30, 2010 on Tuesday, August 31, 2010 after the market
Toggle Summary Presentations at the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop Highlight Clinical Outcomes and Emerging Trends
SUNNYVALE, Calif., July 6, 2010 /PRNewswire via COMTEX/ -- Results Presented in Spine, Lung, Liver and Prostate Treatment Emphasized the Benefits of Whole Body Radiosurgery Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced highlights from the Third
Toggle Summary Accuray Appoints Peter Fine to Board of Directors
SUNNYVALE, Calif., June 29, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the appointment of Peter Fine as a member of the company's Board of Directors effective June 28, 2010.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.